PALVELLA THERAPEUTICS, INC.
About PALVELLA THERAPEUTICS, INC.
Palvella Therapeutics, Inc. (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. The company is headquartered in Wayne, PA. It became publicly traded on Nasdaq via a December 2024 merger with Pieris Pharmaceuticals, after which former Palvella equityholders became majority owners. Palvella has raised a total of $65.4M over 7 rounds since its first funding in 2017.
- 🔗 Palvella Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Institutional investors in Palvella Therapeutics, Inc. (NASDAQ:PVLA) have had a wonderful week after share price increased 13%
- 🔗 Palvella Therapeutics Strategy and Business Model
- 🔗 Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - Mon, 03/02/2026 - 07:30
- 🔗 Palvella Therapeutics Announces Pricing of Upsized Public Offering - Wed, 02/25/2026 - 19:57
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Closed upsized public offering of 1.84M shares in February 2026 including full underwriter option.
- Became Nasdaq-listed (PVLA) via December 2024 merger with Pieris Pharmaceuticals.
- Raised total $65.4M across 7 rounds with 13 institutional investors.
- Lead focus on rare skin diseases and vascular malformations lacking approved therapies.
- CEO Wesley Kaupinen holds 15% ownership stake.
Ask StreetZero about PALVELLA THERAPEUTICS, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account